- Risk of cancer in patients treated with recombinant human growth hormone in childhood
-
Cianfarani S
- KMID: 2452084
- Ann Pediatr Endocrinol Metab.
- 2019 Jun;24(2):92-98.
- doi: 10.6065/apem.2019.24.2.92
Recombinant human growth hormone (GH) has been in use for over 30 years, and its indications have gradually expanded from the classical replacement therapy in GH deficiency (GHD) to pharmacological... -
- CITED
-
- Close
- SHARE
-
- Close
